- Home
- ENR vs RCKT Comparison
ENR vs RCKT Comparison
Compare ENR & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENR
- RCKT
- Stock Information
- Founded
- ENR 2015
- RCKT 1999
- Country
- ENR United States
- RCKT United States
- Employees
- ENR N/A
- RCKT N/A
- Industry
- ENR Industrial Machinery/Components
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- ENR Miscellaneous
- RCKT Health Care
- Exchange
- ENR Nasdaq
- RCKT Nasdaq
- Market Cap
- ENR 1.5B
- RCKT 326.4M
- IPO Year
- ENR N/A
- RCKT N/A
- Fundamental
- Price
- ENR $21.58
- RCKT $2.88
- Analyst Decision
- ENR Hold
- RCKT Buy
- Analyst Count
- ENR 8
- RCKT 13
- Target Price
- ENR $31.63
- RCKT $18.50
- AVG Volume (30 Days)
- ENR 1.1M
- RCKT 4.5M
- Earning Date
- ENR 08-05-2025
- RCKT 08-04-2025
- Dividend Yield
- ENR 5.56%
- RCKT N/A
- EPS Growth
- ENR N/A
- RCKT N/A
- EPS
- ENR 0.74
- RCKT N/A
- Revenue
- ENR $2,901,700,000.00
- RCKT N/A
- Revenue This Year
- ENR $1.77
- RCKT N/A
- Revenue Next Year
- ENR $1.63
- RCKT N/A
- P/E Ratio
- ENR $29.05
- RCKT N/A
- Revenue Growth
- ENR 0.39
- RCKT N/A
- 52 Week Low
- ENR $19.70
- RCKT $2.19
- 52 Week High
- ENR $39.52
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- ENR 50.54
- RCKT 41.23
- Support Level
- ENR $19.78
- RCKT $2.40
- Resistance Level
- ENR $20.66
- RCKT $2.70
- Average True Range (ATR)
- ENR 0.59
- RCKT 0.22
- MACD
- ENR 0.21
- RCKT 0.13
- Stochastic Oscillator
- ENR 91.71
- RCKT 60.76
About ENR Energizer Holdings Inc.
Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.